Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Cecilia WASSBERG"'
Publikováno v:
EJNMMI Research, Vol 7, Iss 1, Pp 1-8 (2017)
Abstract Purpose 18F-fluoride PET/CT exhibits high sensitivity to delineate and measure the extent of bone metastatic disease in patients with prostate cancer. 18F-fluoride PET/CT could potentially replace traditional bone scintigraphy in clinical ro
Externí odkaz:
https://doaj.org/article/d1e0c3832228476fbd86e20c69445768
Autor:
Declan Cahill, Mieke Van Hemelrijck, Fredrik Jäderling, Mats Steinholtz Ahlberg, Hans-Olov Adami, Kerri Beckmann, Helena Bertilsson, Ola Bratt, Lars Egevad, Hans Garmo, Lars Holmberg, Eva Johansson, Antti Rannikko, Cecilia Wassberg, Ulrika W N Åberg, Anna Bill-Axelson
Publikováno v:
BMJ Open, Vol 9, Iss 8 (2019)
Introduction Overtreatment of localised prostate cancer is substantial despite increased use of active surveillance. No randomised trials help define how to monitor patients or when to initiate treatment with curative intent.Methods and analysis A ra
Externí odkaz:
https://doaj.org/article/9e63502ec19e433fbad430044d5819c5
Autor:
Francesca DE LUCA, Martin BOLIN, Lennart BLOMQVIST, Cecilia WASSBERG, Heather MARTIN, Anna FALK DELGADO
Publikováno v:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging.
Attenuation correction (AC) is an important topic in PET/MRI and particularly challenging after brain tumour surgery, near metal implants, adjacent bone and burr holes. In this study, we evaluated the performance of two MR-driven AC methods, ZTE- and
Autor:
Irina Savitcheva, Albert Sundvall, Seppo Koskinen, Cecilia Wassberg, Yousuf Zakko, Rimma Axelsson, Daniel Thor
Publikováno v:
Acta Radiologica. 61:662-667
Background Hybrid SPECT/CT systems allow the shortening of lead time for investigation of cancer patients, since a complementary CT for radiological characterization of focally increased isotope uptake of unclear origin in bone scintigraphy can be pe
Autor:
Albertas Ulys, Stefan Grudén, Niklas Axén, Cecilia Wassberg, Ricardo Rendon, Laurence Klotz, Mindaugas Jievaltas, Teuvo L.J. Tammela, Jonathan L. Giddens, Anders Bjartell, Charlotta Gauffin, Patrick O. Richard, Peter Incze, Kenneth Jansz
BACKGROUND: There is increasing interest in nonmorbid treatments for low- and intermediate-risk prostate cancer with fewer side effects than surgery or radiotherapy. OBJECTIVE: To investigate the tolerability, safety, and antitumor effects of the int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3e200637b5547358a7060a22942d75d
https://trepo.tuni.fi/handle/10024/131774
https://trepo.tuni.fi/handle/10024/131774
Autor:
Lennart Blomqvist, Anna Falk Delgado, Francesca De Luca, Heather Martin, Martin Bolin, Cecilia Wassberg
Publikováno v:
BMC Medical Imaging
Background This study aims to compare proton density weighted magnetic resonance imaging (MRI) zero echo time (ZTE) and head atlas attenuation correction (AC) to the reference standard computed tomography (CT) based AC for 11C-methionine positron emi
Autor:
Håkan Ahlström, Bo Lennernäs, Kimmo Taari, Cecilia Wassberg, Teuvo L.J. Tammela, Michael Häggman, Sam Ladjevardi, Carl-Gustaf Gölander, Catrin von Below, Hans Lennernäs, Niklas Axén, Anna Tolf, T. Isotalo, Jan Weis
Publikováno v:
Journal of Urology. 198:1333-1339
Purpose: We investigated the tolerability, safety and antitumor effects of a novel intraprostatic depot formulation of antiandrogen 2-hydroxyflutamide (in Nano-Zolid (R)) in men with localized prostate cancer. Materials and Methods: Two clinical tria
Autor:
Maria Klockare, Robert Aiken, Johan Harmenberg, Magnus Axelson, Olle Larsson, Cecilia Wassberg
Publikováno v:
Oncotarget
// Robert Aiken 1 , Magnus Axelson 2 , Johan Harmenberg 3 , Maria Klockare 3 , Olle Larsson 4 and Cecilia Wassberg 5 1 Rutgers-Cancer Institute of New Jersey, New Brunswick, NJ, U.S.A 2 Clinical Chemistry, Department of Molecular Medicine and Surgery
Autor:
Cecilia Wassberg, Britt Skogseid, Pantelis Antonodimitrakis, Dan Granberg, Barbro Eriksson, Anders Sundin, Helena Olofsson, Lars Grimelius
Publikováno v:
International Journal of Endocrine Oncology. 4:9-22
Aim: Vasoactive intestinal polypeptide producing neuroendocrine tumors are rare and cause severe hormonal symptoms. Patients/methods: Eighteen patients with vasoactive intestinal polypeptide producing neuroendocrine tumors were analyzed with reviews
Autor:
Mats Steinholtz, Ahlberg, Hans-Olov, Adami, Kerri, Beckmann, Helena, Bertilsson, Ola, Bratt, Declan, Cahill, Lars, Egevad, Hans, Garmo, Lars, Holmberg, Eva, Johansson, Antti, Rannikko, Mieke, Van Hemelrijck, Fredrik, Jäderling, Cecilia, Wassberg, Ulrika W N, Åberg, Anna, Bill-Axelson
Publikováno v:
BMJ Open
Introduction Overtreatment of localised prostate cancer is substantial despite increased use of active surveillance. No randomised trials help define how to monitor patients or when to initiate treatment with curative intent. Methods and analysis A r